Repligen (RGEN) Fails to deliver data

Key failure to deliver metrics for Repligen :

• Last SEC data release: 2025-02-14
• Last 15 days FTD volume: NZ$1.7 M
• Last 3 months FTD volume: NZ$2.92 M
• Last year FTD volume: NZ$2.92 M

A Failure to deliver also known as fails-to-deliver or FTD occurs when a buyer or seller is unable to meet his trading obligations. FTDs for US listed companies are reported to the SEC and published twice a month. Therefore there is a certain delay between the reporting and the publishing of the data.

Failures to deliver for Repligen (RGEN) - 3 months history

Number of shares, 3 months chart

Biweekly Failures to deliver volume for Repligen (RGEN) - since 2013

Repligen (RGEN) Failure to deliver volume, Year over Year

FTD volume in the last 3 months for similar companies or competitors

Company	FTD volume (3 months)	FTD volume (1 year)	Country
Novavax NVAX	NZ$16.12 M	NZ$0.14 B	🇺🇸 USA
BioMarin Pharmaceutical BMRN	NZ$10.13 M	NZ$23.72 M	🇺🇸 USA
Neurocrine Biosciences NBIX	NZ$8.45 M	NZ$26.17 M	🇺🇸 USA
General Electric GE	NZ$0.14 B	NZ$1.41 B	🇺🇸 USA
Thermo Fisher Scientific TMO	NZ$10.99 M	NZ$0.16 B	🇺🇸 USA
Bristol-Myers Squibb BMY	NZ$0.16 B	NZ$0.47 B	🇺🇸 USA
Pfizer PFE	NZ$24.22 M	NZ$0.33 B	🇺🇸 USA
Bio-Techne TECH	NZ$0.22 M	NZ$20.57 M	🇺🇸 USA
Sangamo Therapeutics SGMO	NZ$2.1 M	NZ$6.39 M	🇺🇸 USA
Charles River Laboratories CRL	NZ$10.06 M	NZ$55.37 M	🇺🇸 USA